OPTICENT, INC.

Medtech · Private

Aurora X3 visible-light optical coherence tomography (vis-OCT) system for clinical glaucoma diagnosis and monitoring

Claim this profile

Follows are private to you and power your alerts

Updated · opticenthealth.com

Sector
Medtech
Total capital
$4.2M
Federal grants
$4.2M
8 awards · 2016–2023
Rank in peer group#225 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2020
Rank in peer group#237 of 538

Capital timeline

20162017201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $4.2M$225K$1.2M$573K$706K$779K$253K
2016201820202022FEDERAL ↑EQUITY ↓Cumulative $4.2M$1.2M$573K$706K$779K

Latest events

  • Federal grantHealth and Human S · Phase I · Extraordinary Dispersion Engineering In Enabling Ultrafast Swept Source visiblelight Optical Coherence Tomography$253K
  • Federal grantHealth and Human S · Phase II · Visible-light optical coherence tomography for clinical glaucoma management$779K
  • Federal grantHealth and Human S · Phase II · Visible-light optical coherence tomography for clinical glaucoma management$706K
  • Federal grantHealth and Human S · Phase II · Clinical optical coherence tomography for retinal metabolic imaging$573K
  • Federal grantHealth and Human S · Phase II · Clinical optical coherence tomography for retinal metabolic imaging$1.2M
  • Federal grantHealth and Human S · Phase I · Method for accurate retinal oxygen metabolic rate extraction$225K
  • Federal grantHealth and Human S · Phase I · Clinical optical coherence tomography for retinal metabolic imaging$224K
Show 1 earlier federal award
  • Federal grantNSF · Phase I · STTR Phase I: Low-cost light source development for functional retinal imaging$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#225 · top 42%
  • Granted patents#237 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 2
  • Miftek CorporationSimilar federal contract value in Medtech · null in contracts
  • INNOVATIVE ELEMENTS, LLCSimilar federal contract value in Medtech · null in contracts
  • AIRILABS LLCSimilar federal contract value in Medtech · null in contracts
  • SYNAPTIC HEALTH LLCSimilar federal contract value in Medtech · null in contracts
  • FaceView Mask, LLCSimilar federal contract value in Medtech · null in contracts
  • NeuSpera Medical Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .